Lexicon Pharmaceuticals

$6.90
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.12 (+1.80%) Today

+$0.12 (+1.77%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell LXRX and other stocks, options, and ETFs commission-free!

About LXRX

Lexicon Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of pharmaceutical products for the treatment of human disease. Its drug candidates include XERMELO, Zynquista, and LX9211. The company was founded by Brian P. Zambrowicz and Arthur T. Sands on July 7, 1995 and is headquartered in The Woodlands, TX. The listed name for LXRX is Lexicon Pharmaceuticals, Inc. Common Stock.

CEO

Lonnel Coats

Employees

184

Headquarters

The Woodlands, Texas

Founded

1995

Market Cap

1.03B

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

1.40M

High Today

$6.79

Low Today

$6.00

Open Price

$6.72

Volume

1.69M

52 Week High

$9.65

52 Week Low

$1.03

Analyst Ratings

17%

of 6 ratings

Buy

17%

Hold

83%

Sell

LXRX Earnings

-$0.77

-$0.27

$0.23

$0.73

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Estimated

— per share

Actual

Available Mar 10, After Hours